Kaya Holdings (KAYS) Other financing activities (2021 - 2024)
Kaya Holdings (KAYS) recorded quarterly Other financing activities of $5000.0 in Q1 2024, up 190.37% quarter-over-quarter from -$5533.0 in Q1 2022.
Kaya Holdings (KAYS) Other financing activities (2021 - 2024) Analysis & Trends
Kaya Holdings' Other financing activities history runs 3 years deep, the most recent figure standing at $5000.0 for Q1 2024.
- In Q1 2024, Other financing activities changed N/A year-over-year to $5000.0; the TTM figure through Mar 2024 stood at -$93458.0 (changed N/A YoY), while the FY2023 annual figure was -$12925.0, changed N/A from the prior year.
- Other financing activities was $5000.0 for Q1 2024 at Kaya Holdings, up from -$5533.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $27273.0 in Q2 2021 to a low of -$92925.0 in Q4 2021.
- Historically, Other financing activities has averaged -$16546.2 across 3 years, with a median of -$266.5 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2022 | -5,533.00 |
| Mar 31, 2022 | -5,533.00 |
| Dec 31, 2021 | -92,925.00 |
| Dec 31, 2021 | -92,925.00 |
| Jun 30, 2021 | 27,273.00 |
| Jun 30, 2021 | 27,273.00 |